Showing 1 - 4 results of 4 for search 'Per Nived', query time: 0.03s Refine Results
  1. 1
    Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

    Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacep... by Per Nived, Göran Jönsson, Bo Settergren, Jon Einarsson, Tor Olofsson, Charlotte Sværke Jørgensen, Lillemor Skattum, Meliha C. Kapetanovic

    Published 2020-02-01
    Get full text
    Article
  2. 2
    Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients

    Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients by Per Nived, Åsa Pettersson, Göran Jönsson, Anders A. Bengtsson, Bo Settergren, Lillemor Skattum, Åsa Johansson, Meliha C. Kapetanovic

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

    Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some ext... by Per Nived, Göran Jönsson, Bo Settergren, Jon Einarsson, Tor Olofsson, Charlotte Sværke Jørgensen, Lillemor Skattum, Meliha C. Kapetanovic

    Published 2020-06-01
    Get full text
    Article
  4. 4
    The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

    The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedis... by Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg, Monica Hansson, Sophie Ohlsson, Elisa Pin, Anders Bengtsson, Lars Klareskog, Meliha Kapetanovic

    Published 2024-04-01
    Get full text
    Article

Search Tools: